PMC:7445716 / 53367-53472 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7445716","sourcedb":"PMC","sourceid":"7445716","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7445716","text":"emyelinating\nAIDP NA IVIG 400 mg/kg (5 days) None Improvement of GBS symptoms with persistence of general","divisions":[{"label":"p","span":{"begin":13,"end":17}},{"label":"td","span":{"begin":18,"end":20}},{"label":"td","span":{"begin":21,"end":44}},{"label":"td","span":{"begin":45,"end":49}}],"tracks":[{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T530","span":{"begin":13,"end":17},"obj":"Disease"},{"id":"T531","span":{"begin":65,"end":68},"obj":"Disease"}],"attributes":[{"id":"A530","pred":"mondo_id","subj":"T530","obj":"http://purl.obolibrary.org/obo/MONDO_0020347"},{"id":"A531","pred":"mondo_id","subj":"T531","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"subj":"T530","pred":"source","obj":"LitCovid-PD-MONDO"},{"subj":"T531","pred":"source","obj":"LitCovid-PD-MONDO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T56255","span":{"begin":18,"end":20},"obj":"Chemical"}],"attributes":[{"id":"A54769","pred":"chebi_id","subj":"T56255","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"subj":"T56255","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-MONDO","color":"#ec9793","default":true},{"id":"LitCovid-PD-CHEBI","color":"#93a8ec"}]}]}}